Jeffrey B. Mirviss Boston Scientific Corp (BSX) insider trading activity

Jeffrey B. Mirviss is EVP&Pres, Periph Intervent of BOSTON SCIENTIFIC CORP. Currently has a direct ownership of 28,022 shares of BSX, which is worth approximately $2.55 Million. The most recent transaction as insider was on May 29, 2024, when has been sold 63,802 shares (Common Stock) at a price of $75.1 per share, resulting in proceeds of $4,791,530. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28K

0% 3M change

50.48% 12M change

Total Value Held $2.55 Million

Jeffrey B. Mirviss Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 29 2024	SELL Open market or private sale	$4,791,530 $75.1 p/Share	63,802 Reduced 69.48%	28,022 Common Stock
May 29 2024	BUY Exercise of conversion of derivative security	$582,110 $17.26 p/Share	33,726 Added 26.86%	91,824 Common Stock
Mar 18 2024	SELL Open market or private sale	$963,923 $66.45 p/Share	14,506 Reduced 19.98%	58,098 Common Stock
Feb 21 2024	SELL Open market or private sale	$329,096 $66.35 p/Share	4,960 Reduced 6.39%	72,604 Common Stock
Feb 18 2024	SELL Payment of exercise price or tax liability	$84,578 $65.82 p/Share	1,285 Reduced 1.63%	77,564 Common Stock
Feb 18 2024	BUY Exercise of conversion of derivative security	-	2,817 Added 3.45%	78,849 Common Stock
Feb 17 2024	SELL Payment of exercise price or tax liability	$100,046 $65.82 p/Share	1,520 Reduced 1.96%	76,032 Common Stock
Feb 17 2024	BUY Exercise of conversion of derivative security	-	3,333 Added 4.12%	77,552 Common Stock
Feb 16 2024	SELL Payment of exercise price or tax liability	$89,186 $65.82 p/Share	1,355 Reduced 1.79%	74,219 Common Stock
Feb 16 2024	BUY Exercise of conversion of derivative security	-	2,970 Added 3.78%	75,574 Common Stock
Feb 14 2024	SELL Payment of exercise price or tax liability	$83,492 $65.95 p/Share	1,266 Reduced 1.71%	72,604 Common Stock
Feb 14 2024	BUY Exercise of conversion of derivative security	-	2,776 Added 3.62%	73,870 Common Stock
Feb 06 2024	SELL Payment of exercise price or tax liability	-	12,160 Reduced 14.61%	71,094 Common Stock
Feb 06 2024	BUY Grant, award, or other acquisition	-	26,666 Added 24.26%	83,254 Common Stock
Jan 09 2024	SELL Open market or private sale	$898,941 $59.25 p/Share	15,172 Reduced 21.14%	56,588 Common Stock
Jan 09 2024	BUY Exercise of conversion of derivative security	$247,455 $16.31 p/Share	15,172 Added 17.45%	71,760 Common Stock
Jan 04 2024	SELL Open market or private sale	$876,000 $58.4 p/Share	15,000 Reduced 20.95%	56,588 Common Stock
Jan 04 2024	BUY Exercise of conversion of derivative security	$244,649 $16.31 p/Share	15,000 Added 17.32%	71,588 Common Stock
Jan 03 2024	SELL Open market or private sale	$689,850 $57.82 p/Share	11,931 Reduced 17.41%	56,588 Common Stock
Jan 01 2024	SELL Payment of exercise price or tax liability	$318,417 $57.81 p/Share	5,508 Reduced 7.44%	68,519 Common Stock
Jan 01 2024	BUY Exercise of conversion of derivative security	-	17,439 Added 19.07%	74,027 Common Stock
Dec 06 2023	SELL Open market or private sale	$19,425 $55.03 p/Share	353 Reduced 0.62%	56,588 Common Stock
Dec 03 2023	SELL Payment of exercise price or tax liability	$16,617 $56.14 p/Share	296 Reduced 0.52%	56,941 Common Stock
Dec 03 2023	BUY Exercise of conversion of derivative security	-	649 Added 1.12%	57,237 Common Stock
Nov 08 2023	SELL Bona fide gift	-	4,000 Reduced 6.6%	56,588 Common Stock

JBM

Jeffrey B. Mirviss

EVP&Pres, Periph Intervent

Marlborough, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BSX shares.

Notify only if

Value

Insider Trading

Get notified when an Boston Scientific Corp insider buys or sells BSX shares.

Notify only if

Operation

Value

Type

News

Receive news related to BOSTON SCIENTIFIC CORP

Track Activities on BSX

Account